Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Medicinal Chemistry

• Publication date

  2017-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/0929867323666161101140908PMID 27804869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature

  2015cited by this paper
• Effects of adolescent treatment with nicotine, harmane, or norharmane in male Sprague-Dawley rats.

  2015cited by this paper
• R-(+) and S-(−) Isomers of Cotinine Augment Cholinergic Responses In Vitro and In Vivo

  2015cited by this paper
• Three decomposition products of valepotriates from Valeriana jatamansi and their cytotoxic activity

  2015cited by this paper
• Minor Valepotriates from Valeriana jatamansi and Their Cytotoxicity against Metastatic Prostate Cancer Cells

  2014cited by this paper
• Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice.

  2014cited by this paper
• Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling

  2014cited by this paper
• New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine

  2014cited by this paper
• Cotinine reduces depressive-like behavior and hippocampal vascular endothelial growth factor downregulation after forced swim stress in mice.

  2014cited by this paper
• Contaminant Hepatotoxins as Culprits for Kava Hepatotoxicity – Fact or Fiction?

  2013cited by this paper
• Anti-Inflammatory Activity and Chemical Profile of Galphimia glauca

  2013cited by this paper
• CYP2A6 Genotype but not Age Determines Cotinine Half-life in Infants and Children

  2013cited by this paper
• Saffron, passionflower, valerian and sage for mental health.

  2013cited by this paper
• Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence

  2013cited by this paper
• Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: A randomized controlled trial

  2013cited by this paper
• Kava for the Treatment of Generalized Anxiety Disorder RCT: Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects

  2013cited by this paper
• Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials.

  2013cited by this paper
• Effect of Neurexan on the pattern of EEG frequencies in rats

  2012cited by this paper
• Interactions Between Herbal Medicines and Prescribed Drugs

  2012cited by this paper
• Cotinine enhances the extinction of contextual fear memory and reduces anxiety after fear conditioning.

  2012cited by this paper
• Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data

  2012cited by this paper
• Nicotine-induced anxiogenic-like behaviours of rats in the elevated plus-maze: possible role of NMDA receptors of the central amygdala

  2012cited by this paper
• Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.

  2012cited by this paper
• Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study.

  2012cited by this paper
• Kava, the anxiolytic herb: back to basics to prevent liver injury?

  2011cited by this paper
• A Double‐blind, Placebo‐controlled Investigation of the Effects of Passiflora incarnata (Passionflower) Herbal Tea on Subjective Sleep Quality

  2011cited by this paper
• Oxidative stress and anxiety-like symptoms related to withdrawal of passive cigarette smoke in mice: beneficial effects of pecan nut shells extract, a by-product of the nut industry.

  2011cited by this paper
• Kava hepatotoxicity solution: A six-point plan for new kava standardization.

  2011cited by this paper
• Modulation of the γ‐aminobutyric acid (GABA) system by Passiflora incarnata L.

  2011cited by this paper
• Tradition and toxicity: Evidential cultures in the kava safety debate

  2011cited by this paper
• Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence.

  2011cited by this paper
• Interaction of the natural anxiolytic Galphimine-B with serotonergic drugs on dorsal hippocampus in rats.

  2011cited by this paper
• Chilean Experimental Version of the State-Trait Depression Questionnaire (ST–DEP): State Subscale (S–DEP)

  2010cited by this paper
• Re-introduction of Kava (Piper methysticum) to the EU: Is There a Way Forward?

  2010cited by this paper
• Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.

  2009cited by this paper
• Kava and St. John's Wort: Current Evidence for Use in Mood and Anxiety Disorders

  2009cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder

  2009cited by this paper
• The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish.

  2008cited by this paper
• Potential for interactions between dietary supplements and prescription medications.

  2008cited by this paper
• Toxicity of Kava Kava

  2008cited by this paper
• Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.

  2008cited by this paper
• Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.

  2008cited by this paper
• Toxicological and cytotoxic evaluation of standardized extracts of Galphimia glauca.

  2007cited by this paper
• Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system.

  2007cited by this paper
• Efficacy and Tolerability of a Standardized Herbal Product from Galphimia glauca on Generalized Anxiety Disorder. A Randomized, Double-Blind Clinical Trial Controlled with Lorazepam

  2007cited by this paper
• Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivatives.

  2006cited by this paper
• Safety of St. John's Wort extract compared to synthetic antidepressants.

  2006cited by this paper
• Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca.

  2006cited by this paper
• Anxiolytic effects of a combination of Melissa ofcinalis and Valeriana ofcinalis during laboratory induced stress

  2006cited by this paper
• Analysis of convergent and discriminant validity of the Spanish experimental version of the State-Trait Depression Questionnaire (ST-DEP).

  2005cited by this paper
• St John's wort for depression

  2005cited by this paper
• Hypnotic activities of chamomile and passiflora extracts in sleep-disturbed rats.

  2005cited by this paper
• An Internet-Based Randomized, Placebo-Controlled Trial of Kava and Valerian for Anxiety and Insomnia

  2005cited by this paper
• Adverse effects of St. John's Wort: a systematic review.

  2004cited by this paper
• Discontinuation and reinstitution of medications during the perioperative period.

  2004cited by this paper
• Effect of valerian on human sleep

  2004cited by this paper
• Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers.

  2004cited by this paper
• Attenuation of Laboratory-Induced Stress in Humans After Acute Administration of Melissa officinalis (Lemon Balm)

  2004cited by this paper
• Impact of federal safety advisories on health food store advice

  2004cited by this paper
• Mechanism of Action of St John’s Wort in Depression

  2003cited by this paper
• Nicotine dependence and psychiatric disorders.

  2003cited by this paper
• Galphimine B Modulates Synaptic Transmission on Dopaminergic Ventral Tegmental Area Neurons

  2003cited by this paper
• Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.

  2003cited by this paper
• Do different mechanisms underlie two anxiogenic effects of systemic nicotine?

  2003cited by this paper
• Kava-Kava administration reduces anxiety in perimenopausal women.

  2003cited by this paper
• Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties.

  2003cited by this paper
• An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers.

  2003cited by this paper
• Anti-inflammatory actions of St. John's wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation.

  2003cited by this paper
• Interaction between Fluvoxamine and Cotinine or Caffeine

  2002cited by this paper
• Herbal kava: reports of liver toxicity.

  2002cited by this paper
• INTERINDIVIDUAL DIFFERENCES IN NICOTINE METABOLISM AND GENETIC POLYMORPHISMS OF HUMAN CYP2A6

  2002cited by this paper
• CYP2A6 genetic variation and potential consequences.

  2002cited by this paper
• Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury

  2002cited by this paper
• Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo‐controlled pilot study

  2002cited by this paper
• Genetic Variation in CYP2A6-Mediated Nicotine Metabolism Alters Smoking Behavior

  2002cited by this paper
• Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm).

  2002cited by this paper
• Interactions between herbal medicines and prescribed drugs: a systematic review.

  2001cited by this paper
• Passionflower in the treatment of generalized anxiety: a pilot double‐blind randomized controlled trial with oxazepam

  2001cited by this paper
• Inhibition of human cytochrome P450 2E1 by nicotine, cotinine, and aqueous cigarette tar extract in vitro.

  2001cited by this paper
• Passionflower in the treatment of opiates withdrawal: a double‐blind randomized controlled trial

  2001cited by this paper
• The use of complementary and alternative therapies to treat anxiety and depression in the United States.

  2001cited by this paper
• Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.

  2000cited by this paper
• GABAA and GABAB antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo

  1999cited by this paper
• Flavonoids and the Central Nervous System: from Forgotten Factors to Potent Anxiolytic Compounds

  1999cited by this paper
• Mania associated with St. John's wort.

  1999cited by this paper
• St. John's wort and hypomania.

  1998cited by this paper
• Effects of cotinine on cigarette self-administration

  1998cited by this paper
• Cotinine: effects with and without nicotine

  1998cited by this paper
• Effects of cotinine on information processing in nonsmokers

  1998cited by this paper
• Safety of cotinine in humans: physiologic, subjective, and cognitive effects.

  1997cited by this paper
• Sedative Effect of Galphimine B, a Nor- seco -triterpenoid from Galphimia glauca

  1993cited by this paper
• The Effects of Valerian, Propranolol, and their Combination on Activation, Performance, and Mood of Healthy Volunteers under Social Stress Conditions

  1988cited by this paper
• Stimulation of [3H]Dopamine Release by Nicotine in Rat Nucleus Accumbens

  1987cited by this paper
• Psychometric properties of the STAI: a reply to Ramanaiah, Franzen, and Schill.

  1984cited by this paper
• Cotinine disposition and effects

  1983cited by this paper
• Valepotriates, a new class of cytotoxic and antitumor agents.

  1981cited by this paper
• On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons.

  1979cited by this paper
• Self-rating depression scale in an outpatient clinic. Further validation of the SDS.

  1965cited by this paper

• Medicinal Plants and Herbal Medicines for Managing Anxiety and Depression via Gut Microbiota Modulation

  2025cites this paper
• Sedum kamtschaticum Exerts Hypnotic Effects via the Adenosine A2A Receptor in Mice

  2024cites this paper
• Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases

  2023cites this paper
• Ethnobotanical and Ethnopharmacological Study in the Bulgarian Mountain Rhodopes: Part II—Contemporary Use of Medicinal Plants

  2023cites this paper
• γ‐Lactam‐Based Antifungal Compounds against the Wheat Pathogen Zymoseptoria tritici

  2021cites this paper
• Research Progress on Natural Compounds Exerting an Antidepressant Effect through Anti-inflammatory.

  2021cites this paper
• Prevalence of complementary and alternative medicine (CAM) use in Brazil

  2020cites this paper
• Preparation of isoquercitrin by biotransformation of rutin using α-L-rhamnosidase from Aspergillus niger JMU-TS528 and HSCCC purification

  2020cites this paper
• Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies—A Comprehensive Review

  2020cites this paper
• Medicinal plants as natural polarizers of macrophages: Phytochemicals and Pharmacological effects.

  2019cites this paper
• Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent.

  2019cites this paper
• Rutin as neuroprotective agent: from bench to bedside.

  2019cites this paper
• Autism Spectrum Disorders: Potential Neuro-Psychopharmacotherapeutic Plant-Based Drugs.

  2018cites this paper
• Extracts of Physalis peruviana Protect Astrocytic Cells Under Oxidative Stress With Rotenone

  2018cites this paper
• Intranasal cotinine improves memory, and reduces depressive‐like behavior, and GFAP+ cells loss induced by restraint stress in mice

  2017cites this paper